BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33000269)

  • 1. lncRNA TINCR facilities bladder cancer progression via regulating miR‑7 and mTOR.
    Xu G; Yang H; Liu M; Niu J; Chen W; Tan X; Sun L
    Mol Med Rep; 2020 Nov; 22(5):4243-4253. PubMed ID: 33000269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p.
    Yu S; Wang D; Shao Y; Zhang T; Xie H; Jiang X; Deng Q; Jiao Y; Yang J; Cai C; Sun L
    Aging (Albany NY); 2019 Mar; 11(5):1389-1403. PubMed ID: 30853664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of lncRNA TINCR is associated with high-grade, invasive, and recurring tumors, and facilitates proliferation in vitro and in vivo of urothelial carcinoma of the bladder.
    Han Y; Sun G
    Urol Oncol; 2020 Sep; 38(9):738.e1-738.e8. PubMed ID: 32622721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis.
    Han X; Jia Y; Chen X; Sun C; Sun J
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34542165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer.
    Liu X; Ma J; Xu F; Li L
    Biomed Pharmacother; 2018 Mar; 99():9-17. PubMed ID: 29324317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R.
    Guo F; Zhu X; Zhao Q; Huang Q
    Int J Mol Med; 2020 Sep; 46(3):989-1002. PubMed ID: 32705168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
    Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
    Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
    Qin A; Qian W
    Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
    Zhao H; Xie Z; Tang G; Wei S; Chen G
    J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
    Chen Q; Fu L
    PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA TINCR SNPs and Expression Levels Are Associated with Bladder Cancer Susceptibility.
    Xu C; Liu M; Jia D; Tao T; Hao D
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):31-41. PubMed ID: 33372851
    [No Abstract]   [Full Text] [Related]  

  • 12. Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
    Li R; Wang Y; Xu Y; He X; Li Y
    Int J Oncol; 2019 Nov; 55(5):1110-1124. PubMed ID: 31545411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
    Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
    Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.
    Liu Y; Gao S; Du Q; Zhao Q
    Int J Mol Med; 2019 Jan; 43(1):547-556. PubMed ID: 30387807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer.
    Wang C; Tao W; Ni S; Chen Q
    J Cell Biochem; 2019 Jan; 120(1):357-367. PubMed ID: 30168179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted Article: lncRNA TINCR sponges miR-214-5p to upregulate ROCK1 in hepatocellular carcinoma.
    Hu M; Han Y; Zhang Y; Zhou Y; Ye L
    BMC Med Genet; 2020 Jan; 21(1):2. PubMed ID: 31900116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells.
    Chen Z; Liu Y; He A; Li J; Chen M; Zhan Y; Lin J; Zhuang C; Liu L; Zhao G; Huang W; Cai Z
    Sci Rep; 2016 Sep; 6():30798. PubMed ID: 27586866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
    Xue M; Pang H; Li X; Li H; Pan J; Chen W
    Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.